antithymocyte globulin + cyclosporine + etanercept + everolimus

This is a combination regimen consisting of four immunosuppressive agents: - **Antithymocyte globulin (ATG):** A polyclonal antibody preparation that depletes T lymphocytes through complement-mediated lysis, apoptosis, and modulation of immune cell surface molecules. It also induces regulatory T cells and interferes with dendritic cell function, providing broad immunomodulation[1][3][5][7]. - **Cyclosporine:** A calcineurin inhibitor that suppresses the immune system by inhibiting interleukin-2 production in T cells (not detailed in provided results but well-established). - **Etanercept:** A fusion protein acting as a tumor necrosis factor (TNF) inhibitor, blocking the activity of TNF-alpha and reducing inflammation (not detailed in provided results but well-established). - **Everolimus:** An mTOR inhibitor that blocks the mammalian target of rapamycin pathway, thereby inhibiting cell growth, proliferation, angiogenesis, and immune responses. It is used both as an anticancer agent and to prevent organ rejection after transplantation[6][8][10]. This combination may be used experimentally or off-label for conditions requiring profound immunosuppression such as severe aplastic anemia or prevention/treatment of transplant rejection.